Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Common-Size Balance Sheet: Assets

Allergan PLC, common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Cash and cash equivalents 2.64 0.86 1.54 1.34 0.81
Short-term investments 3.60 1.01 2.38 6.25 0.01
Teva shares 0.00 0.00 1.54 2.67 0.00
Marketable securities 3.60% 1.01% 3.91% 8.92% 0.01%
Accounts receivable, net 3.37 2.82 2.45 1.96 1.77
Inventories 1.20 0.83 0.76 0.56 0.74
Current assets held for sale 0.00 0.03 0.00 0.00 2.61
Prepaid taxes 0.46 0.40 0.58 0.74 0.18
Prepaid insurance 0.01 0.02 0.02 0.02 0.02
Contingent income 0.09 0.07 0.07 0.07 0.01
Sales and marketing 0.07 0.04 0.03 0.03 0.03
Other 0.30 0.28 0.25 0.20 0.18
Prepaid expenses and other current assets 0.94% 0.80% 0.95% 1.07% 0.41%
Current assets 11.75% 6.36% 9.61% 13.84% 6.34%
Property, plant and equipment, net 2.03 1.76 1.51 1.25 1.16
Right of use asset, operating leases 0.52 0.00 0.00 0.00 0.00
Deferred executive compensation investments 0.09 0.09 0.09 0.09 0.09
Equity method investments 0.01 0.01 0.01 0.01 0.01
Cost method investments 0.00 0.00 0.00 0.01 0.01
Other long-term investments 0.07 0.04 0.05 0.05 0.06
Taxes receivable 0.04 1.65 0.03 0.03 0.03
Contingent income 0.05 0.07 0.00 0.00 0.00
Other assets 0.16 0.08 0.04 0.03 0.23
Investments and other assets 0.43% 1.94% 0.23% 0.22% 0.43%
Non current assets held for sale 0.03 0.87 0.07 0.02 7.76
Deferred tax assets 0.61 1.05 0.27 0.18 0.04
Product rights and other intangibles 40.01 42.93 46.18 48.55 50.01
Goodwill 44.61 45.11 42.13 35.94 34.27
Non current assets 88.25% 93.64% 90.39% 86.16% 93.66%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan PLC current assets as a percentage of total assets decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Allergan PLC property, plant and equipment, net as a percentage of total assets increased from 2017 to 2018 and from 2018 to 2019.
Non current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Allergan PLC non current assets as a percentage of total assets increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.